Health Care & Life Sciences » Biotechnology | Spark Therapeutics Inc.

Spark Therapeutics Inc.

Spark Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
37.57 M
Public Float
18.71 M
Spark Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.36
Market Cap
$3.89 B
Shares Outstanding
38.41 M
Public Float
34.81 M

Profile

Address
3737 Market Street
Philadelphia Pennsylvania 19104
United States
Employees -
Website http://www.sparktx.com
Updated 07/08/2019
Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A.

Financials

View All

Katherine A. High
President, Director & Head-Research & Development
Jeffrey D. Marrazzo
Chief Executive Officer & Director